Genscript Biotech Market Cap

Genscript Biotech has a market cap or net worth of 29.21 billion as of December 12, 2025. Its market cap has increased by 27.33% in one year.

Market Cap

29.21B

Enterprise Value

26.19B

Revenue

6.50B

Ranking

n/a

PE Ratio

1.20

Stock Price

13.38

Market Cap Chart

Since December 30, 2015, Genscript Biotech's market cap has increased from 2.11B to 29.21B, an increase of 1,282.95%. That is a compound annual growth rate of 30.19%.

Market Cap History

Date	Market Cap	% Change
Dec 11, 2025	29.21B	38.45%
Dec 31, 2024	21.10B	-49.96%
Dec 29, 2023	42.16B	-19.78%
Dec 30, 2022	52.56B	-27.50%
Dec 31, 2021	72.50B	229.03%
Dec 31, 2020	22.03B	-33.64%
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro
Dec 31, 2015	Upgrade Pro	Upgrade Pro
Dec 30, 2015	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
BeOne Medicines AG	274.43B
Hansoh Pharmaceutical Group Company	257.41B
JD Health International	188.25B
Innovent Biologics	144.64B
WuXi Biologics	138.62B
Sino Biopharmaceutical	121.03B
Akeso	109.98B
Sichuan Kelun-Biotech Biopharmaceutical	96.12B

Market Cap Rankings